Discussion
Cure Sanfilippo Foundation and the National MPS Society are investing $5.5 million to expand access to an experimental treatment for children with Sanfilippo syndrome type B. The funding will support a U.S.-based expanded access program expected to launch as early as October for tralesinidase alfa (TA-ERT), an…